Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 28Insulin Resistance 6Infertility 3Hyperandrogenism 3Pre-Eclampsia 2Metabolic Syndrome 2Infertility, Female 2Glucose Intolerance 2Diabetes, Gestational 2Weight Loss 1Thyroid Nodule 1Premature Birth 1Periodontitis 1Menstruation Disturbances 1Inflammation 1Hodgkin Disease 1Anovulation 1

Interventions

Clomiphene 10Metformin 9Letrozole 3Medroxyprogesterone Acetate 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Ultrasonography 1Tamoxifen 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Inulin 1Inositol 1Hematologic Tests 1Glycoprotein Hormones, alpha Subunit 1Folic Acid 1Flutamide 1Chorionic Gonadotropin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anovulation × Inositol × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡